How much does erlotinib cost? How to determine dosage and dosage period?

Erlotinib is already on the market in China and is included in medical insurance, and patients can purchase it in hospitals and pharmacies. According to the reimbursement situation of medical insurance, the patient's out-of-pocket amount is usually around a few hundred yuan, but the specific price may vary depending on the region, hospital and medical insurance reimbursement ratio. Patients should consult their local hospital pharmacy to obtain the latest medical insurance reimbursement prices when purchasing.

For foreign markets, the price of erlotinib is relatively low, especially for generic drugs. Generic drugs from Laos are a relatively cheap option, priced at around four hundred yuan. This kind of generic drug has basically the same ingredients as the original drug and can provide patients with more economical treatment options. For those patients who are not covered by health insurance, purchasing generic medications may be an option worth considering.

As for the dosage and period of administration of erlotinib, they are generally determined based on the patient’s condition and treatment plan. For patients with non-small cell lung cancer, the usually recommended dose is 150 mg taken orally once daily. Treatment is usually continued until disease progression or unacceptable side effects occur. Patients should check regularly during the medication period to ensure the efficacy of the medication, and adjust the dosage according to the doctor's recommendations.
When taking erlotinib, patients should follow their doctor's instructions and do not adjust the dosage or dosage cycle on their own. Some patients may experience minor side effects, such as rash, diarrhea, etc. These conditions can usually be alleviated through medication adjustment or symptomatic treatment. Therefore, patients need to communicate closely with their doctors during the treatment process to ensure medication safety and achieve the best therapeutic effect.
Reference: https://en.wikipedia.org/wiki/Erlotinib